Statement on influenza vaccination for the 2006-2007 season. An Advisory Committee Statement (ACS).
D000081:Acetamides / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000368:Aged; D000547:Amantadine / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D002170:Canada / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D004196:Disease Outbreaks / Q000517:prevention & control; D024882:Drug Resistance, Viral; D005260:Female; D006282:Health Personnel; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D053118:Influenza A Virus, H1N1 Subtype; D053122:Influenza A Virus, H3N2 Subtype; D053124:Influenza A Virus, H5N1 Subtype; D009980:Influenza A virus; D009981:Influenza B virus; D007252:Influenza Vaccines / Q000627:therapeutic use*; D005585:Influenza in Birds / Q000517:prevention & control; D007251:Influenza, Human / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D053139:Oseltamivir; D011200:Poultry / Q000821:virology; D011247:Pregnancy
D000081:Acetamides; D000998:Antiviral Agents; D007252:Influenza Vaccines; D053139:Oseltamivir; D000547:Amantadine